Drug · CHEMBL121663

DEQUALINIUM CHLORIDE

7 sourcespipelines-2026-09-18-0.3.1

Cite this record

ConductScience Library. DEQUALINIUM CHLORIDE. Drugs and targets, record CHEMBL121663. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL121663

On this page

Drug

Names and IDs as ChEMBL gives them, through Open Targets.

Name: DEQUALINIUM CHLORIDE; ChEMBL
ChEMBL ID: CHEMBL121663; ChEMBL
Type: Small molecule; ChEMBL
Brand names: Dequacets, Dequadin, Fluomizin, Labosept; ChEMBL
Other names: BAQD 10, BAQD-10, Chlorure de dequalinium, Cloruro de decualinio, Decamine, Dekamin, Dequalinium dichloride, GNF-PF-5483, NSC-166454, Nordman; ChEMBL
Parent form: DEQUALINIUM, CHEMBL333826; Drugs and targets
InChIKey: LTNZEXKYNRNOGT-UHFFFAOYSA-N; ChEMBL
Open Targets' highest stage: Approval, as Open Targets' drug record gives it; Open Targets

Targets0

The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.

None in this release.

Diseases1

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Disease	Open Targets' stage	Stage reported by	Reports	Of them trials	Its drugs
bacterial vaginosis	Phase 3	ClinicalTrials.gov	2	2	https://conductscience.org/library/drugs?q=MONDO_0005316

Source Open Targets

Trials4

Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.

Trial	Title	Phase	Participants	Results first posted	Named as	Linked by	Source
NCT05788991	Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis	Phase 4	151	2024-10-16	dequalinium chloride	Its name	ClinicalTrials.gov
NCT01125410	Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis	Phase 3	321		dequalinium chloride	Its name	ClinicalTrials.gov
NCT02242695	Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis	Phase 4	150		dequalinium chloride	Its name	ClinicalTrials.gov
NCT04057482	Treatment of BV With Donaxyl and a Molecular Test of Cure		58		dequalinium chloride	Its name	ClinicalTrials.gov

Comparisons in its trials4

Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.

Comparison	Group 1, with the outcome	Group 2, with the outcome	Participants	Trial	Source
Dequalinium Chloride vs Metronidazole: deaths from any cause	0 of 72	0 of 75	147	NCT05788991	Trial comparisons
Dequalinium Chloride vs Metronidazole: serious adverse events	0 of 72	0 of 75	147	NCT05788991	Trial comparisons
Dequalinium Chloride vs Metronidazole: Clinical Cure Rate	64 of 69	69 of 74	143	NCT05788991	Trial comparisons
Dequalinium Chloride vs Metronidazole: Clinical Cure Rate	55 of 69	62 of 71	140	NCT05788991	Trial comparisons

Papers from its trials3

The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it	Source
38696172	RESULT	1	PubMed
32940765	DERIVED	1	PubMed
22205034	DERIVED	1	PubMed

Tests in its trials0

The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.

None in this release.

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
ClinicalTrials.gov: 2026-11-05; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
Papers the trials list, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
Tests named in the trials, as ScienceGraph matched them: 2026-11-12; ConductCognition

Sources 7

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ConductCognition's list of its testsOur own data
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this drug from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL121663

GET https://conductscience.org/api/drugs/v1/CHEMBL121663/targets

API reference For AI assistants